SE411904B - Forfarande for framstellning av steroidderivat tillhorande androstan-serien - Google Patents

Forfarande for framstellning av steroidderivat tillhorande androstan-serien

Info

Publication number
SE411904B
SE411904B SE7509650A SE7509650A SE411904B SE 411904 B SE411904 B SE 411904B SE 7509650 A SE7509650 A SE 7509650A SE 7509650 A SE7509650 A SE 7509650A SE 411904 B SE411904 B SE 411904B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
steroid derivatives
androstan
series
Prior art date
Application number
SE7509650A
Other languages
English (en)
Swedish (sv)
Other versions
SE7509650L (sv
Inventor
G H Phillipps
B M Bain
J C Clark
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of SE7509650L publication Critical patent/SE7509650L/xx
Publication of SE411904B publication Critical patent/SE411904B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
SE7509650A 1974-08-30 1975-08-29 Forfarande for framstellning av steroidderivat tillhorande androstan-serien SE411904B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38089/74A GB1517278A (en) 1974-08-30 1974-08-30 Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates

Publications (2)

Publication Number Publication Date
SE7509650L SE7509650L (sv) 1976-03-01
SE411904B true SE411904B (sv) 1980-02-11

Family

ID=10401103

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7509650A SE411904B (sv) 1974-08-30 1975-08-29 Forfarande for framstellning av steroidderivat tillhorande androstan-serien

Country Status (12)

Country Link
US (1) US3981894A (uk)
JP (1) JPS5148648A (uk)
BE (1) BE832888A (uk)
CH (1) CH612687A5 (uk)
DE (1) DE2538627A1 (uk)
DK (1) DK136075B (uk)
FR (1) FR2282898A1 (uk)
GB (1) GB1517278A (uk)
IE (1) IE41662B1 (uk)
NL (1) NL7510225A (uk)
SE (1) SE411904B (uk)
ZA (1) ZA755554B (uk)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3002746A1 (de) * 1980-01-23 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin 1-hydroxysteroide, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
SI1775305T1 (sl) * 2000-08-05 2015-01-30 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
SI1383786T1 (sl) * 2001-04-30 2009-02-28 Glaxo Group Ltd Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof

Also Published As

Publication number Publication date
BE832888A (fr) 1976-03-01
DK136075C (uk) 1978-01-09
AU8440375A (en) 1977-03-03
DK389375A (uk) 1976-03-01
GB1517278A (en) 1978-07-12
IE41662L (en) 1976-02-29
CH612687A5 (uk) 1979-08-15
US3981894A (en) 1976-09-21
FR2282898B1 (uk) 1978-11-10
DK136075B (da) 1977-08-08
JPS5148648A (uk) 1976-04-26
DE2538627A1 (de) 1976-03-11
SE7509650L (sv) 1976-03-01
ZA755554B (en) 1976-08-25
IE41662B1 (en) 1980-02-27
FR2282898A1 (fr) 1976-03-26
NL7510225A (nl) 1976-03-02

Similar Documents

Publication Publication Date Title
SE411904B (sv) Forfarande for framstellning av steroidderivat tillhorande androstan-serien
SE419605B (sv) Forfarande for framstellning av undertrycksformad gjutform
NO144418C (no) Fremgangsmaate til fremstilling av klorerte etenderivater
SE7513085L (sv) Forfarande for framstellning av etrar
SE426828B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner eller 6beta-acylamino-6alfa-alkoxipenicilliner
SE423996B (sv) Forfarande for framstellning av daunomycin- och adriamycin-derivat
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7901000L (sv) Forfarande for framstellning av terpenoidestrar av steroider
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE405976B (sv) Forfarande for framstellning av anti-inflammatoriska steroider tillhorande androstan-serien
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE419646B (sv) Forfarande for framstellning av 8-halogen-dibensofuran-3-ettiksyra-derivat
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7507648L (sv) Forfarande for framstellning av basiskt substituerade derivat av 4-hydroxi-bensimidazol
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE414028B (sv) Forfarande for framstellning av terapeutisk verksamma fentiazinderivat
SE7508654L (sv) Forfarande for framstellning av steroider
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider